| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | NEKTAR THERAPEUTICS COM | 500,000 | 6,135,000 | 0.14% | Call | |
| 52 | NEUROCRINE BIOSCIE COM USD0.001 | 150,000 | 5,805,000 | 0.13% | ||
| 53 | SAREPTA THERAPEUTICS INC | 200,000 | 5,486,000 | 0.12% | ||
| 54 | BIOTIME INC | 1,282,050 | 4,628,000 | 0.10% | ||
| 55 | IGNYTA INC COM | 850,000 | 4,505,000 | 0.10% | ||
| 56 | E L F BEAUTY INC | 150,000 | 4,341,000 | 0.10% | ||
| 57 | MACROGENICS INC | 200,000 | 4,088,000 | 0.09% | ||
| 58 | CHEMOCENTRYX INC | 546,278 | 4,042,000 | 0.09% | ||
| 59 | NEUROCRINE BIOSCIE COM USD0.001 | 100,000 | 3,870,000 | 0.09% | Call | |
| 60 | ACCELERON PHARMA INC | 150,000 | 3,828,000 | 0.08% | ||
| 61 | RADIUS HEALTH INCORPORATED COM NEW | 100,000 | 3,803,000 | 0.08% | ||
| 62 | JUNO THERAPEUTICS INC COM | 200,000 | 3,770,000 | 0.08% | ||
| 63 | Axovant Sciences LTD | 300,000 | 3,726,000 | 0.08% | ||
| 64 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 246,054 | 3,555,000 | 0.08% | ||
| 65 | ULTRAGENYX PHARMACEUTICAL INC COM | 50,000 | 3,516,000 | 0.08% | ||
| 66 | INTELLIA THERAPEUTICS INC | 250,000 | 3,278,000 | 0.07% | ||
| 67 | AC IMMUNE SA | 250,000 | 3,245,000 | 0.07% | ||
| 68 | AMICUS THERAPEUTICS INC COM | 650,000 | 3,231,000 | 0.07% | Call | |
| 69 | LOXO ONCOLOGY INC COM | 100,000 | 3,212,000 | 0.07% | ||
| 70 | REGENXBIO INC COM | 160,000 | 2,968,000 | 0.07% | ||
| 71 | MINERVA NEUROSCIENCES INC COM | 251,300 | 2,953,000 | 0.07% | ||
| 72 | CELLECTIS S A | 150,000 | 2,543,000 | 0.06% | ||
| 73 | SPARK THERAPEUTICS INCORPORATED | 50,000 | 2,495,000 | 0.06% | ||
| 74 | CELLDEX THERAPEUTICS INC NEW | 675,000 | 2,390,000 | 0.05% | ||
| 75 | CHIMERIX INC | 500,000 | 2,300,000 | 0.05% | ||
| 76 | CLOVIS ONCOLOGY INC | 50,000 | 2,221,000 | 0.05% | ||
| 77 | NOVELION THERAPEUTICS INC | 256,400 | 2,159,000 | 0.05% | ||
| 78 | AGENUS INC | 500,000 | 2,060,000 | 0.05% | Call | |
| 79 | JUNO THERAPEUTICS INC COM | 100,000 | 1,885,000 | 0.04% | Call | |
| 80 | MEDICINES CO | 50,000 | 1,697,000 | 0.04% | ||
| 81 | AIMMUNE THERAPEUTICS INC COM | 81,600 | 1,669,000 | 0.04% | ||
| 82 | ZAFGEN INC COM | 500,000 | 1,590,000 | 0.04% | ||
| 83 | NANTKWEST INC COM | 225,000 | 1,287,000 | 0.03% | ||
| 84 | ADAPTIMMUNE THERAPEUTICS PLC | 300,000 | 1,215,000 | 0.03% | ||
| 85 | ADURO BIOTECH INC | 100,000 | 1,140,000 | 0.03% | ||
| 86 | DIMENSION THERAPEUTICS INC | 234,493 | 1,020,000 | 0.02% | ||
| 87 | ACHAOGEN INC COM | 60,000 | 781,000 | 0.02% | ||
| 88 | NOVAVAX INC COM | 500,000 | 630,000 | 0.01% | ||
| 89 | CEMPRA INC | 200,000 | 560,000 | 0.01% | ||
| 90 | ONCOCYTE CORP | 64,102 | 452,000 | 0.01% | ||
| 91 | COLUCID PHARMACEUTICALS ORD | 5,575 | 203,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-17-006297, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
